(Q44407150)

English

Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study

scientific article published on 26 March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study (English)

1 reference

Europe PubMed Central

2 December 2017

cholecystokinin

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hans-Jürgen Möller

8

object named as

H-J Möller

1 reference

Europe PubMed Central

2 December 2017

author name string

P Zwanzger

1

1 reference

Europe PubMed Central

2 December 2017

D Eser

2

1 reference

Europe PubMed Central

2 December 2017

S Aicher

3

1 reference

Europe PubMed Central

2 December 2017

C Schüle

4

1 reference

Europe PubMed Central

2 December 2017

T C Baghai

5

1 reference

Europe PubMed Central

2 December 2017

F Padberg

6

1 reference

Europe PubMed Central

2 December 2017

R Ella

7

1 reference

Europe PubMed Central

2 December 2017

R Rupprecht

9

1 reference

Europe PubMed Central

2 December 2017

language of work or name

0 references

publication date

26 March 2003

1 reference

Europe PubMed Central

2 December 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

2 December 2017

28

1 reference

Europe PubMed Central

2 December 2017

979-984

1 reference

Europe PubMed Central

2 December 2017

5

1 reference

Europe PubMed Central

2 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300131

0 references

Persistent respiratory irregularity in patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Long-term benzodiazepine treatment reduces neuronal responsiveness to cholecystokinin: an electrophysiological study in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Neuroendocrine effects of benzodiazepines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Measurement of lactate-induced panic and anxiety.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

CCK in animal and human research on anxiety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Benzodiazepines increase preprocholecystokinin messenger RNA levels in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Neuroendocrine effects of diazepam in panic and generalized anxiety disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Adrenocorticotropin hormone response to diazepam in healthy young men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Cholecystokinin in anxiety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Release of cholecystokinin from rat cerebral cortex in vivo: role of GABA and glutamate receptor systems.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

21 January 2018

Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

7 January 2021

based on heuristic

inferred from DOI database lookup

Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

7 January 2021

based on heuristic

inferred from DOI database lookup

Afternoon cortisol levels before (spontaneous) and after suppression with dexamethasone or oxazepam in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

7 January 2021

based on heuristic

inferred from DOI database lookup

Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin- immunoreactive material

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300131

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300131

0 references

1 reference

Europe PubMed Central

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44407150&oldid=2021361331"